Tg Therapeutics TGTX
NASDAQ TGTX
$54.29 +0.67 (+1.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Return on Assets [ROA] (2012 - 2026)

Updated

Tg Therapeutics (TGTX) recorded Return on Assets [ROA] of 27.86% in Q2 2026, up 18.97 percentage points from 8.90% a year earlier but down 7.77 percentage points from the prior quarter.

Analysis

Tg Therapeutics (TGTX) Return on Assets [ROA] (2012 - 2026) Analysis & Trends

For FY2025, Tg Therapeutics reported Return on Assets [ROA] of 54.50%, up 49.35 percentage points from FY2024.

  • Annual Return on Assets [ROA] has increased for seven straight years, with a five-year change of +125.35 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at 5.15% in FY2024 (+0.31 pp), 4.84% in FY2023 (+74.05 pp), -69.20% in FY2022 (+0.05 pp) and -69.26% in FY2021 (+1.59 pp).
  • Quarterly Return on Assets [ROA] has ranged from -104.02% in Q2 2022 to 51.80% in Q3 2025 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased for four consecutive quarters, with an average year-over-year change of +15.91 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 108.71 percentage points in Q2 2024, against a drop of 41.34 percentage points in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 35.64% (Q1 2026), 42.83% (Q4 2025) and 51.80% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Tg Therapeutics 8.31 Bn 7.70 Bn 199.14 Mn 27.86%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.86%
Mar 31, 2026 35.64%
Dec 31, 2025 42.83%
Sep 30, 2025 51.80%
Jun 30, 2025 8.90%
Mar 31, 2025 6.34%
Dec 31, 2024 4.02%
Sep 30, 2024 -2.91%
Jun 30, 2024 24.71%
Mar 31, 2024 11.72%
Dec 31, 2023 3.84%
Sep 30, 2023 -9.39%
Jun 30, 2023 -84.00%
Mar 31, 2023 -86.23%
Dec 31, 2022 -96.40%
Sep 30, 2022 -101.66%
Jun 30, 2022 -104.02%
Mar 31, 2022 -95.65%
Dec 31, 2021 -88.20%
Sep 30, 2021 -76.98%
API Access

Tg Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TGTX&period=max&api_key=YOUR_API_KEY